The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study

Hyperprolactinemia is a frequent consequence of treatment with antipsychotics. Earlier studies have indicated that terguride, which is a partial dopamine agonist, reduces the prolactin levels that are induced by prolactinemia. Thus, we examined the dose effects of adjunctive treatment with terguride...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Kojiro, Sugawara, Norio, Ishioka, Masamichi, Nakamura, Kazuhiko, Yasui-Furukori, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149438/
https://www.ncbi.nlm.nih.gov/pubmed/25187719
http://dx.doi.org/10.2147/NDT.S68298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149438/
https://www.ncbi.nlm.nih.gov/pubmed/25187719
http://dx.doi.org/10.2147/NDT.S68298

Ejemplares similares